EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Engineered extracellular vesicle-encapsulated CHIP as novel nanotherapeutics for treatment of renal fibrosis

Cheng Ji, Jiahui Zhang, Linru Shi, Hui Shi, Wenrong Xu, Jianhua Jin, Hui Qian

npj Regenerative Medicine · 13.01.2024 · 9 (1)

DOI: 10.1038/s41536-024-00348-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift npj Regenerative Medicine, online erschienen am 13.01.2024. Verfasst von Cheng Ji und 6 weiteren Autor:innen. Beteiligte Einrichtung: Wujin Institute of Molecular Diagnostics and Precision Cancer Medicine of Jiangsu University, Wujin Hospital Affiliated with Jiangsu University, Chan…. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China (National Science Foundation of China), Basic Research Program of Jiangsu Province, China Postdoctoral Science Foundation.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Renal interstitial fibrosis (RIF) is a fundamental pathological feature of chronic kidney disease (CKD). However, toxicity and poor renal enrichment of fibrosis inhibitors limit their further applications. In this study, a platform for CKD therapy is developed using superparamagnetic iron oxide nanoparticles (SPION) decorated mesenchymal stem cells derived extracellular vesicles with carboxyl terminus of Hsc70-interacting protein (CHIP) high expression (SPION-EVs) to achieve higher renal-targeting antifibrotic therapeutic effect. SPION-EVs selectively accumulate at the injury renal sites under an external magnetic field. Moreover, SPION-EVs deliver CHIP to induce Smad2/3 degradation in renal tubular cells which alleviates Smad2/3 activation-mediated fibrosis-like changes and collagen deposition. The extracellular vesicle engineering technology provides a potential nanoplatform for RIF therapy through CHIP-mediated Smad2/3 degradation.

Autor:innen und Institutionen

  • Wujin Institute of Molecular Diagnostics and Precision Cancer Medicine of Jiangsu University, Wujin Hospital Affiliated with Jiangsu University, Chang Zhou, Jiangsu, China.
  • Jiangsu Key Laboratory of Medical Science and Laboratory Medicine, School of Medicine, Department of laboratory Medicine, Jiangsu University, Zhenjiang, China.
  • Wujin Institute of Molecular Diagnostics and Precision Cancer Medicine of Jiangsu University, Wujin Hospital Affiliated with Jiangsu University, Chang Zhou, Jiangsu, China. jianhuajin88@sina.com.
  • Wujin Institute of Molecular Diagnostics and Precision Cancer Medicine of Jiangsu University, Wujin Hospital Affiliated with Jiangsu University, Chang Zhou, Jiangsu, China. lstmmmlst@163.com.
  • Jiangsu Key Laboratory of Medical Science and Laboratory Medicine, School of Medicine, Department of laboratory Medicine, Jiangsu University, Zhenjiang, China. lstmmmlst@163.com.

Förderung

  • National Natural Science Foundation of China (National Science Foundation of China)
  • Basic Research Program of Jiangsu Province
  • China Postdoctoral Science Foundation

Zitieren

APA

Ji, C., Zhang, J., Shi, L., Shi, H., Xu, W., Jin, J., & Qian, H. (2024). Engineered extracellular vesicle-encapsulated CHIP as novel nanotherapeutics for treatment of renal fibrosis. npj Regenerative Medicine, 9(1). https://doi.org/10.1038/s41536-024-00348-0

Vancouver

Ji C, Zhang J, Shi L, Shi H, Xu W, Jin J, et al. Engineered extracellular vesicle-encapsulated CHIP as novel nanotherapeutics for treatment of renal fibrosis. npj Regenerative Medicine. 2024;9(1). doi:10.1038/s41536-024-00348-0

BibTeX
@article{Ji2024,
  author = {Ji, Cheng and Zhang, Jiahui and Shi, Linru and Shi, Hui and Xu, Wenrong and Jin, Jianhua and Qian, Hui},
  title = {Engineered extracellular vesicle-encapsulated CHIP as novel nanotherapeutics for treatment of renal fibrosis},
  journal = {npj Regenerative Medicine},
  year = {2024},
  volume = {9},
  number = {1},
  doi = {10.1038/s41536-024-00348-0}
}
Kostenlos starten →